NCT04459312

Brief Summary

The investigators will analyze the presence of antibodies against SARS-COV2 in physicians working in emergency and intensive care medicine and in those who treat Covid 19 patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 3, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 7, 2020

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

July 8, 2020

Status Verified

July 1, 2020

Enrollment Period

1 month

First QC Date

July 3, 2020

Last Update Submit

July 6, 2020

Conditions

Antibody COVID-19

Outcome Measures

Primary Outcomes (1)

  • Presence of antibodies against SARS-COV2

    3 months

Interventions

Antibody test (SARS-CoV2)DIAGNOSTIC_TEST

Antibody test

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All physicians working in german hospitals in emergency or intensive care medicine

You may qualify if:

  • Qualified as physician

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Duesseldorf, Dept. of Anesthesiology

Düsseldorf, 40225, Germany

RECRUITING

MeSH Terms

Interventions

Antibody Formation

Intervention Hierarchy (Ancestors)

Immunity, ActiveAdaptive ImmunityImmunityImmune System Phenomena

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Detlef Kindgen-Milles

Study Record Dates

First Submitted

July 3, 2020

First Posted

July 7, 2020

Study Start

June 1, 2020

Primary Completion

July 10, 2020

Study Completion

September 30, 2020

Last Updated

July 8, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations

DE(1)